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Abstract 
In recent years, the parallel artificial membrane permeability assay (PAMPA) has been extended for 
prediction of skin permeation by developing an artificial membrane which mimics the stratum corneum 
structure, skin-PAMPA. In the present work, the different parameters affecting skin-PAMPA permeability, 
such as incubation time and stirring, have been studied to establish ideal assay conditions to generate 
quality data for a screening of active pharmaceutical ingredients (API) in early stage drug discovery. 
Another important parameter is membrane retention, which shows dependence on lipophilicity when 
compounds are in their neutral form. Furthermore, the stability of the membrane has been investigated at 
different pH values, especially at basic pHs. Finally, a good correlation between human skin permeability 
and skin-PAMPA permeability, with a large dataset (n = 46), has been established. The optimized assay 
conditions were an incubation time of 4 hours with stirring in a pH below 8. With all these considerations 
the thickness of the aqueous boundary layer is decreased as much as possible and the membrane stability 
is guaranteed.  
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Introduction 
Transdermal administration is considered as an alternative route to conventional oral delivery of drugs. 
Transdermal delivery offers significant advantages over oral administration: minimal first-pass metabolism, 
avoidance of the adverse effects in the gastrointestinal environment and the ability to provide a controlled 
and prolonged drug release [1]. Despite these advantages, the structure of the skin mainly composed of the 
stratum corneum (SC), the outermost layer which acts as the main penetration barrier, the viable epidermis 
and dermis, imposes a clear obstacle to the topical delivery of drugs into the systemic bloodstream. 
Estimation of skin permeation has become crucial in the pharmaceutical and cosmetic industries. Among 
the in vitro models used to determine the skin permeation, Franz diffusion cell method applying human skin 
as a membrane is the most relevant [2], but this method is laborious, costly and ethically questionable. 
Besides, it suffers low intra- and inter-laboratory reproducibility. The parallel artificial membrane 
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permeability assay (PAMPA) was developed by Kansy and co-workers [3] for the fast determination of the 
permeability through passive diffusion. This technique is crucial in the early stage of drug discovery and it 
has many advantages like low cost and high-throughput. The first published models allowed the prediction 
of gastrointestinal absorption (GIT-PAMPA) [4–6]. Then, other models were published for modelling the 
blood-brain barrier [7] and also for the estimation of skin permeation [8]. Later, Sinkó and co-workers 
developed the skin-PAMPA methodology consisting of a new membrane containing synthetic certramides, 
analogues of the ceramides found in the stratum corneum [9,10]. Certramides are cheaper alternatives to 
natural ceramides with the potential to prolong the storage time. Although certramides are structurally 
different from ceramides, their comparable molecular mass and hydrogen bond acceptor/donor capacity 
enables them to act as the lipid constituents in the PAMPA sandwich membrane, together with cholesterol, 
stearic acid and silicone oil [9,10]. Skin-PAMPA is a model that offers high reproducibility, is more cost-
effective and less laborious than other in vitro skin experiments, and has demonstrated a high prediction 
capability with a good correlation with the human skin penetration data [10].  
GIT PAMPA assay conditions such as permeation time, assay pH, stirring, use of cosolvents and selection 
of detection techniques have been studied during years and optimized to generate high quality and 
relevant data [5]. For skin-PAMPA, only a few articles have been published [10,11] and most of them deal 
with liquid or semi-solid formulations [12,13] and transdermal patches [14]. However, permeability studies 
of compounds in solution are very important when the permeation properties of API are investigated. The 
protocol of these studies depends on the physico-chemical parameters of the API and the composition of 
the membrane. Since the skin-PAMPA membrane contains different components and is more resistive 
compared to other PAMPA membranes, protocol differences as incubation time are expected. The reason 
for this is that PAMPA membranes are composed mostly of lipophilic components and hence lipophilic 
compounds can cross them quickly. However, skin-PAMPA consists of lipophilic and hydrophilic moieties, so 
permeable compounds are likely to cross both lipophilic and hydrophilic domains [10]. Another parameter 
that also depends on the composition membrane and physico-chemical properties of the API is the 
unstirred water layer (UWL), which is formed around both sides of the lipophilic membrane. The 
permeation process in PAMPA assays may be limited by the UWL, especially for lipophilic compounds. The 
water layer can act as rate-limiting transport giving smaller permeability values. To solve this, the stirring 
decreases the UWL thickness and thus the resistance of the water layer less of a contribution to the 
measured permeability [15]. The use of the oblate stir disks (flippers), rotating in a horizontal axis parallel 
to the plane of the microtitre plates, proved to be the most efficient stirring mechanism ever reported in 
microtitre plate permeation assays [15].  
Another feature to consider is the stability of the membrane. Human skin pH is normally slightly acidic, 
values between 4 and 6, while the body’s internal environment mainly maintains a neutral pH. Fatty acids 
found in the lipid bilayer exist in the neutral or ionic forms depending on the pH, so they also contribute to 
the ionization of the membrane. At the SC surface, pH 5 causes minimal head‐group repulsion and 
promotes a bilayer structure. The pH 7 in the innermost SC layers produces 90 % ionization of the fatty 
acids leading to head‐group repulsion. An increase of the pH leads to increase head‐group repulsion, 
disturbing epidermal lipid lamella and thus impairing barrier function [16]. As most of the drugs are weak 
acids or weak bases, it is relevant to study the influence of the pH on permeability. To this end, it is 
necessary to study the stability of the skin-PAMPA membrane at different pH values, especially at basic 
pHs.  
In order to establish the optimal assay conditions to generate quality data for the screening of API in 
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early stage drug discovery, the purposes of this work are to study the different parameters affecting skin-
PAMPA permeability, such as incubation time and stirring, and also to check the stability of the membrane 
with pH. 
Materials and methods  
Reagents 
Acetonitrile LiChrosolv grade was purchased from Merck (Darmstadt, Germany). Formic acid was 
obtained from Scharlau (Sentmenat, Spain). Dimethylsulphoxide was from Carlo Erba (Milano, Italy). Water 
was purified by a Milli-Q deionizing system from Millipore (Billerica, MA, USA) with a resistivity of 18.2 MΩ. 
Most solutes employed were purchased from Sigma-Aldrich (Steinheim, Germany), Fluka Analytical VWR 
(West Chester, PA, USA), Riedel-de Haën (Seelze, Germany), Merck (Darmstadt, Germany), Carlo Erba 
(Milano, Italy) and Baker (Center Valley, PA, USA). Some drugs were synthesized in ESTEVE (Barcelona, 
Spain). 
The concentrated PRISMA HTTM solution was used to prepare the buffer solutions. This solution is a 
universal buffer designed by Pion Inc (Billerica, MA, USA) and is formed by several compounds with pKa 
values evenly spaced to produce a constant buffer capacity in the range pH 3-10. The ionic strength of the 
PRISMA HTTM is about 10 mM. A hydration solution from Pion Inc. (Billerica, MA, USA) was used to 
rehydrate the artificial skin membrane. 
The skin-PAMPA plates, with a membrane composed by certramides, cholesterol, stearic acid, and 
silicone oil, were also obtained from Pion Inc. (Billerica, MA, USA). 
Instruments 
pH measurements were done with a combined Crison 5202 electrode in a Crison 2001 pH meter (Hach 
Lange Spain, L’Hospitalet de Llobregat, Spain). The electrode system was calibrated with the ordinary 
aqueous buffers of pH 4.01 and 7.00 (25 °C). 
Permeability measurements were made with the PAMPA Explorer Permeability Assay instrument from 
Pion Inc (Billerica, MA, USA). This instrument is composed of the Gut-BoxTM and the TempPlate. The Gut-
BoxTM is a mechanical device used for the PAMPA assay to decrease the permeation time and reduce the 
unstirred water layer (UWL) thickness that is always present. The TempPlate is used for the temperature 
control during plate incubation. 
Chromatographic measurements were performed with a Waters (Milford, MA, USA) I-Class UPLC with 
diode array detector. Instrument control and processing was performed by Empower. The column used for 
the determinations was an Acquity UPLC BEH C18 (50 x 2.1 mm, 1.7 μm).  
Skin-PAMPA method 
Before permeation assays, the top part of the skin-PAMPA sandwich, which contains the membrane, 
was hydrated overnight with the hydration solution. The samples were dissolved in diluted PRISMA HTTM 
buffer solution at several pH values: 25 mL of concentrated PRISMA HTTM was diluted with water to a final 
volume of 1 L and then, different solutions were prepared by pH adjustment between 3 and 10 with 0.5 M 
NaOH (Merck). The concentration of the sample solutions was 50 µM (containing 0.5 % v/v DMSO). Skin-
PAMPA assays were carried out under gradient-pH conditions to mimic the pH change between the stratum 
corneum and the underlying epidermis and dermis. For this reason, the donor compartment pH was varied 
from 3 to 10 and the acceptor compartment pH was maintained at pH 7.4. This gradient-pH state is the first 
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sink condition in skin-PAMPA. The double-sink condition that is usually used in GIT-PAMPA consists in 
taking advantage of chemical scavengers in the receiver compartment to make permeation of lipophilic 
compounds across the membrane unidirectional. This procedure simulates the situation present in the 
body where blood flow and serum proteins constantly shift the concentration gradient to favor absorption. 
However, this double-sink condition is not used in skin-PAMPA since this additional shift is not observed 
through the skin. Before performing the skin-PAMPA sandwich, the donor compartment (or bottom plate) 
was prefilled with 180 µL (stirred assay) or 200 µL (unstirred assay) of sample solutions and the acceptor 
compartment (or top plate) was filled with 200 µL of PRISMA HTTM buffer solution at pH 7.4. The donor 
volume is decreased in stirred assay since the stirring bars have a volume of 20 µL that can cause overflow. 
As it is mentioned before, the Gut-BoxTM was used to stir effectively. 
The skin-PAMPA sandwich was incubated at 32 °C. After the permeation time was reached, the plates 
were separated and the compound concentration in acceptor, donor and reference (initial sample solution) 
was determined using UPLC-DAD. Chromatographic conditions were: formic acid 0.1 % and acetonitrile as 
mobile phase, flow rate of 0.8 mL/min, linear gradient elution (linear gradient from 2 % to 98 % of 
acetonitrile in 2.5 minutes), injection volume of 5 μL and the detection by DAD. 3 to 5 replicate 
measurements were done per compound and pH, and every well-plate contained only one compound. 
Calculation methods 
The skin-PAMPA permeability was calculated through PAMPA equations. Taking into account the 
membrane retention (mole fraction of the sample that can be lost in the membrane) under gradient-pH 
conditions, the equations are the following [17]: 
Pe = -
2.303VD
A·(t-tss)·εa
· (
1
1+ra
) ·log10 [- ra+ (
1+ ra
1-RM
) ·
CD(t)
CD(0)
]    (1) 
RM = 1-
CD(t)
CD(0)
-
VA
VD
CA(t)
CD(0)
   (2) 
where Pe is the effective permeability coefficient (cm/s), VD and VA are the volume of solution in the 
donor side (180 µL stirred assay or 200 µL unstirred assay) and acceptor side (200 µL), respectively, A is the 
membrane area (0.3 cm2), t is the incubation time of the experiment (s), τss is the lag time (s) 
[τss=(54·RM+1)·60 s], εa is the apparent membrane porosity (0.76), CD(t) is the concentration in the donor 
side at time t, CD(0) is the initial concentration in the donor side, CA(t) is the concentration in the acceptor 
side at time t, RM is the membrane retention and ra is the sink asymmetry ratio (gradient-pH-induced), 
defined as: 
ra= (
VD
VA
)
Pe(A→D)
Pe(D→A)
                                                                                                                     (3) 
When the pH is different in the two sides of the membrane, a gradient-pH is created and the 
permeation of ionizable molecules can be altered. This gradient-pH implies two different permeability 
coefficients, one denoted by the superscript (D→A), associated with donor to acceptor flux, and the other 
denoted by the superscript (A→D), corresponding to the reverse-direction flux. As equation (3) has two 
unknowns, Pe(A→D) and Pe(D→A), the following method is used to solve the equation: at least two assays are 
done, one with gradient-pH and the other with iso-pH, that is, the same pH at both compartments. For iso-
pH, Pe(A→D) = Pe(D→A). Therefore, Pe(A→D) can be solved directly using the iso-pH equation: 
Pe= -
2.303VD
A·(t-tss)·εa
· (
1
1+rV
) ·log10 [-rV+ (
1+ rV
1-RM
) ·
CD(t)
CD(0)
]                                                                                                  (4) 
where rv is the aqueous compartment volume ratio, defined as: 
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rV = 
VD
VA
                                                                                                                                                                   (5) 
Then, Eq. (1) is iteratively solved for Pe(D→A). Initially, ra is assumed to be rv, but with each iteration, the ra 
estimation is improved by using the calculated Pe(D→A). The process continues until self-consistency is 
reached within the precision required (0.001). The Solver utility from Microsoft Excel was used for the 
iterative process.   
Results and discussion 
Optimization of skin-PAMPA assay conditions: incubation time and stirring 
To evaluate the different parameters that affect skin-PAMPA permeability and to establish general assay 
conditions for skin-PAMPA determinations in solution, the permeability of 9 drugs with different acid-base 
properties, lipophilicity, and in vitro Franz Cell human skin permeability values (Kp, units in cm/s) was 
investigated. To assure the neutral form, acidic compounds (flurbiprofen, ibuprofen, naproxen and 5-
fluorouracil) were dissolved in PRISMA HTTM buffer solution at pH 3.0. Aminopyrine, a basic compound with 
a aqueous pKa value of 5, was dissolved in the buffer solution at pH 7.0. The neutral compounds 
(progesterone, griseofulvin, digitoxin and hydrocortisone) were dissolved at pH 3.0. The skin-PAMPA 
sandwiches were incubated (with and without stirring) for 30 min, 4 h and 24 h. The logarithm of skin-
PAMPA permeability values (log Pe) and the corresponding membrane retention are presented in Table 1. 
This table also shows the logarithm of the octanol-water partition coefficient (log Po/w) and the logarithm of 
human skin permeation coefficient (log Kp) for each compound. The log Kp data was obtained from Zhang et 
al. database [18]. This database provides an extensive and carefully examined data set, where experimental 
log Kp data from literature is corrected for ionization in water and for the temperature at 37 °C.  
Table 1. log Pe values of the neutral form of the drugs, obtained from skin-PAMPA assays with and without stirring at 
different incubation times. 
    log Pe 
    With stirring Without stirring 
Solutes 
log Kp 
[18] 
log Po/w 
[19] 
pKa 30 min 4 h 24 h 30 min 4 h 24 h 
5-Fluorouracil -6.82 -0.89 7.86 
a
 - -5.77(±0.02) -6.16(±0.03) - -6.47(±0.22) -6.07(±0.06) 
Aminopyrine -6.55 0.80 5.00 
b
 -5.88(±0.07) -5.65(±0.01) -5.17(±0.06) -5.79(±0.06) -5.46(±0.06) -5.22(±0.02) 
Digitoxin -8.15 2.83  - - -6.42(±0.27) - - -6.34(±0.13) 
Flurbiprofen -4.72 4.16 4.19 
c
 -2.98(±0.13) -3.69(±0.02) - -3.54(±0.06) -3.85(±0.03) - 
Griseofulvin -6.44 2.18  -5.61(±0.01) -5.25(±0.10) -5.12(±0.02) -5.65(±0.05) -5.33(±0.07) -5.20(±0.05) 
Hydrocortisone -7.22 1.61  - -6.13(±0.03) -6.04(±0.07) - -6.30(±0.18) -6.14(±0.08) 
Ibuprofen -4.58 3.50 4.43 
d
 -2.71(±0.04) -3.61(±0.05) - -3.59(±0.08) -3.65(±0.04) - 
Naproxen -4.97 3.34 4.28 
e
 -3.96(±0.12) -4.19(±0.02) - -3.99(±0.08) -4.24(±0.06) - 
Progesterone -4.90 3.87  -3.25(±0.25) -4.11(±0.10) -4.59(±0.15) -4.81(±0.06) -4.88(±0.22) -4.69(±0.12) 
a
 From reference [20], 
b
 From reference [19], 
c
 From reference [21], 
d
 From reference [22], 
e
 From reference [23] 
First, to study the effect of the incubation time and stirring in the determination of the skin permeability 
through the skin-PAMPA permeability, the log Kp values were correlated to the log Pe obtained from skin-
PAMPA assays at each incubation time. The correlations obtained are presented in Figure 1 A-C. Each figure 
contains two different correlations, one for the stirred assays and another for unstirred assays. As it can be 
observed, the number of compounds that can be determined in 4 hours (n=8) is greater than in 30 minutes 
(n=6) and 24 hours (n=6). For some compounds, such as 5-fluorouracil, hydrocortisone and digitoxin, whose 
log Kp values are quite low, an incubation time of 30 minutes is not enough to reach the steady state, 
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therefore their skin-PAMPA permeability values cannot be evaluated. After 4 hours of incubation, all drugs 
can be determined except digitoxin which does not arrive at the steady state. Digitoxin is considered very 
little permeable due to its very low in vitro skin permeability value (log Kp = -8.15). After 24 hours of 
incubation, digitoxin can reach the steady state and its skin-PAMPA permeability values can be determined. 
However, compounds such as flurbiprofen, ibuprofen and naproxen (with high log Kp values) cannot be 
determined. When a compound is highly permeable, long incubation times under gradient-pH conditions 
provoke that the donor and acceptor compartment concentrations achieve equilibrium values and hence 
the whole sample of the donor compartment moves to acceptor compartment due to sink conditions, 
making difficult to determine the permeability values.  
 
Figure 1. Effect of incubation time and stirring in the determination of the skin permeability (log Kp) through 
the skin-PAMPA permeability (log Pe). Incubation time: 30 minutes (A); 4 hours (B); 24 hours (C); stirred assay 
(●); non-stirred assay (⨉). 
Relative to stirring and non-stirring experiments, Table 1 shows the results obtained at different 
incubation times. At 30 minutes of incubation time flurbiprofen, progesterone and ibuprofen show great 
log Pe values in stirred assays compared to unstirred ones. This difference can be attributed to the presence 
of UWL due to the lipophilic character of the compounds (log Po/w > 3). In this case, UWL acts as rate-
limiting transport giving smaller permeability values. At 4 hours of incubation, log Pe values obtained from 
experiments with and without stirring are almost the same except for progesterone (log Pe equal to – 4.11 
and -4.88, respectively) and 5-fluorouracil (log Pe equal to - 5.77 and -6.47, respectively). For progesterone, 
this difference can be justified by the presence of UWL or the high membrane retention values. The reason 
for 5-fluorouracil is unknown since it is a very hydrophilic compound and therefore the difference of values 
cannot be attributed to UWL effect. In general, it seems that with 4 hours of incubation time the aqueous 
boundary layer does not have much effect in most compounds. At 24 hours, apart from flurbiprofen, 
ibuprofen, and naproxen which couldn’t be evaluated, the results obtained with and without stirring are 
practically the same. 
The membrane retention values can sometimes be very high depending on the composition of the 
PAMPA membrane. For example, membranes made of 2 % DOPC (dioleoylphosphatidylcholine) dissolved in 
dodecane can have RM values higher than 0.80 [4]. In the case of the skin-PAMPA membrane, retention is in 
general low and goes from 0 to 0.30 for most of the analyzed compounds (see Table 2), except for 
progesterone whose values are very high (0.33-0.88). For some compounds this parameter can depend on 
the incubation time. For 5-fluorouracil, aminopyrine, and hydrocortisone this parameter is almost null; 
minimum retention is observed only after 24 h of incubation. Note that these compounds are quite 
hydrophilic and are almost neutral at the pH of the determination. Instead, for some other compounds 
such as digitoxin, griseofulvin and progesterone (all neutral compounds but with higher log Po/w values) RM 
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clearly increases with incubation time. In the case of flurbiprofen, ibuprofen and naproxen, RM decreases as 
the incubation time increases. These compounds are completely ionized at the pH of the acceptor 
compartment, and after some time they are all accumulated in there, showing negligible retention in the 
membrane. In general terms, this factor is independent of stirring or not the solutions as observed for all 
compounds except for progesterone, which retention factor increases with the stirring use. 
Table 2. Membrane retention values of the neutral form of the drugs, obtained from skin-PAMPA assays with and without 
stirring at different incubation times. 
    RM 
    With stirring Without stirring 
Solutes 
log Kp 
[18] 
log Po/w 
[19] 
pKa 30 min 4 h 24 h 30 min 4 h 24 h 
5-Fluorouracil -6.82 -0.89 7.86 
a
 0.00 0.04(±0.04) 0.08(±0.03) 0.00 0.01(±0.03) 0.05(±0.02) 
Aminopyrine -6.55 0.80 5.00 
b
 0.00 0.00 0.05(±0.02) 0.00 0.04(±0.01) 0.05(±0.02) 
Digitoxin -8.15 2.83  0.00 0.22(±0.04) 0.29(±0.05) 0.00 0.09(±0.03) 0.25(±0.02) 
Flurbiprofen -4.72 4.16 4.19 
c
 0.18(±0.03) 0.00 0.00 0.13(±0.02) 0.00 0.00 
Griseofulvin -6.44 2.18  0.06(±0.01) 0.19(±0.01) 0.24(±0.02) 0.03(±0.02) 0.16(±0.01) 0.20(±0.02) 
Hydrocortisone -7.22 1.61  0.02(±0.00) 0.01(±0.01) 0.08(±0.03) 0.00 0.04(±0.01) 0.07(±0.02) 
Ibuprofen -4.58 3.50 4.43 
d
 0.22(±0.03) 0.00 0.00 0.19(±0.07) 0.09(±0.03) 0.00 
Naproxen -4.97 3.34 4.28 
e
 0.13(±0.03) 0.00 0.00 0.09(±0.02) 0.04(±0.02) 0.00 
Progesterone -4.90 3.87  0.50(±0.04) 0.74(±0.01) 0.88(±0.01) 0.33(±0.01) 0.62(±0.04) 0.83(±0.02) 
a
 From reference [20], 
b
 From reference [19], 
c
 From reference [21], 
d
 From reference [22], 
e
 From reference [23] 
The membrane retention values at 24 h incubation time have been correlated to the log Po/w to check if 
membrane retention is related to lipophilicity. Flurbiprofen, ibuprofen, and naproxen are excluded from the 
correlation due to the reasons above mentioned. A sigmoidal relationship between RM and log Po/w, which 
can be explained by equation 6 (see appendix), can be observed for the rest of the drugs, which are mainly 
in its neutral form. 
RM =
1
1+10
-logD+log
Vwater
Vmembrane
                    (6) 
  
 
 
 
 
 
 
Figure 2. Relationship between membrane retention (RM) 
and lipophilicity (log Po/w) at 24 h incubation time without 
stirring. 
 
 
In this equation D is the distribution coefficient between water and membrane (pH dependent), Vwater is the 
volume of the aqueous compartment, and Vmembrane is the volume of the membrane. Figure 2 shows the fit 
of equation 6 (using Po/w of the compounds instead of log D) to the experimental data (24 h incubation time 
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without stirring). Good statistics are obtained (R2 = 0.951, SD = 0.066, F = 98), with a value of 3.19 ± 0.11 for 
the parameter log (Vwater/Vmembrane).  This is a good fit given that the true equilibrium may not have been 
achieved, ionisation of some compounds has been neglected, and octanol is expected to be more lipophilic 
than the membrane. 
From correlations established in Figure 1 A-C, it can be observed that the slopes are very close and very 
low data dispersion is observed. Hence, the assay conditions using an incubation time of 4 hours (Figure 1B) 
and taking advantage of stirring to decrease as much as possible the thickness of the aqueous boundary 
layer are considered the most appropriate. Working under these conditions permits to evaluate the 
greatest number of compounds, despite in some cases, such as digitoxin, longer incubation might be 
needed.  
Study of membrane stability 
The stability of the skin-PAMPA membrane at basic pH values was studied through measurement of the 
permeability of 11 compounds (3 acids, 5 bases and 3 neutrals). The skin-PAMPA membrane was hydrated 
with diluted PRISMA HTTM buffer solution at pH 7, 8, 9 and 10 during 30 min and 4 hours, to be consistent 
with incubation times selected in section 3.1. Then, a standard permeation assay was carried out with an 
incubation time of 4 h and stirring at pH 5 in the donor compartment and pH 7.4 in the acceptor 
compartment. Simultaneously, permeation assays were also performed without the previous soaking 
treatment at basic pH. The obtained results are presented in Figure 3, which shows the skin-PAMPA log Pe 
values obtained with and without the previous treatment. Each subfigure corresponds to a compound and 
the straight line inside the figure is the log Pe value in the untreated membrane. 
An increase of permeability values at pH 9 and 10 is shown in Figure 3 for almost all the compounds, 
which points out the lack of stability of the membrane in this pH range. In some cases, such as aminopyrine, 
some distortion is already noted at pH 8. As described in the literature [16], solutions at pH 7 or higher 
produce a change of membrane packaging in human skin. However, in the skin-PAMPA membrane loose of 
stability is not observed up to pH 8, probably due to the different membrane composition. In most cases, 
the permeability values increase for both 30 minutes and 4 hours of treatment, meaning that at 30 minutes 
the stability of the membrane is already altered by the basic pH. Griseofulvin and warfarin have a slight 
increase at pH 9 and 10. The values of indomethacin, 2-toluidine and sufentanyl, however, remain constant. 
As a general trend, it seems that this problem is more important when the compound is less permeable 
(log Pe below -5) regardless of the nature and ionization of the compound. In conclusion, although the 
PRISMA HTTM universal buffer solution suggests a working pH range between 3 and 10, it is advisable not to 
exceed pH 8 to avoid damaging the skin-PAMPA membrane. In that cases where permeability must be 
determined at pH values higher than eight (for example to determine the log Pe of the neutral forms of 
bases with pKa values higher than 7) alternative methods should be used, such the estimation equations 
proposed by Zhang et al. [18] or estimation through chromatographic measurements [24]. 
Correlation with human skin permeation data 
The skin-PAMPA permeability (Pe) of a large acid-base drugs dataset (n=46) obtained in the optimized 
assay conditions previously discussed has been correlated with literature skin permeability (Kp). The log Kp 
data were collected from Zhang et. al. database [18]. Table 3 shows the log Kp and log Pe values of the 
compounds used in the correlation. Each compound was measured at the pH corresponding to the neutral 
form. Figure 4 plots the log Kp vs. the log Pe values whose correlation is presented in Eq. (7): 
log Kp = - 0.143(±0.403) + 1.156(±0.080) log Pe                                                                                                    (7) 
Martí Rosés et al.  ADMET & DMPK 8(1) (2020) 16-28 
 
24  
 
n = 46 R2 = 0.826 SD = 0.434 F = 208 
A good correlation between human skin and skin-PAMPA data and adequate statistical parameters have 
been obtained. 
 
Figure 3. Influence of treatment time and pH in skin-PAMPA permeability. Treatment time: 30 minutes (▲); 4 
hours (∎). 
Table 3. log Kp and log Pe experimental values of the neutral form of the drugs. 
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Both Kp and Pe in cm/s units.  
Solutes log Kp [18] log Pe 
2,4-Dichlorophenol -4.30 -3.92± 0.00 
2-Isopropyl-5-Methylphenol (Thymol) -4.35 -4.01± 0.00 
2-Nitro-p-phenylenediamine -6.66 -5.25±0.02 
3-Methylphenol (m-Cresol) -4.89 -4.33±0.01 
4-Amino-2-nitrophenol -5.91 -4.59±0.02 
4-Chlorophenol -4.52 -4.270.02± 
4-Ethylphenol -4.53 -4.19±0.02 
4-Hydroxyphenylacetamide -6.89 -6.07±0.08 
4-Hydroxy-methylphenylacetate -5.26 -5.07±0.09 
4-Nitrophenol -5.33 -4.91±0.02 
5-Fluorouracil -6.82 -5.77±0.02 
8-Methoxypsoralen -5.12 -4.30±0.03 
5,5-Diethylbarbituric acid (Barbital) -7.29 -5.75±0.05 
5-Ethyl-5-phenylbarbituric acid (Phenobarbital) -6.68 -6.05±0.01 
Benzoic acid -5.68 -4.82±0.07 
4-Hydroxybenzyl alcohol -6.26 -5.85±0.01 
Aminopyrine -6.55 -5.67±0.03 
Aniline -4.94 -4.55±0.00 
Benzyl nicotinate -4.87 -4.16±0.02 
Caffeine -6.85 -5.45±0.02 
Catechol -5.87 -5.39±0.00 
Cortexolone -7.20 -5.45±0.03 
Corticosterone -6.84 -5.59±0.01 
Cortisone -7.38 -6.09±0.02 
Dexamethasone -7.27 -6.25±0.03 
Diclofenac -5.30 -3.79±0.02 
Digitoxin -8.15 -6.38±0.15 
Estradiol -5.61 -4.15±0.07 
Fluocinonide -6.33 -5.38±0.06 
Flurbiprofen -4.72 -3.69±0.01 
Griseofulvin -6.44 -5.28±0.06 
Hydrocortisone -7.22 -6.17±0.05 
Hydroquinone -6.31 -5.87±0.06 
Hydroxyprogesterone -6.30 -4.70±0.05 
Ibuprofen -4.58 -3.61±0.06 
Indomethacine -5.39 -4.40±0.04 
Isoquinoline -5.11 -4.20±0.01 
Ketoprofen -5.22 -4.68±0.03 
Methyl 4-hydroxybenzoate -5.12 -4.88±0.04 
Methyl phenyl ether (Anisole) -4.68 -4.34±0.04 
Naproxen -4.97 -4.19±0.04 
o-Phenylenediamine -6.70 -5.42±0.02 
Piroxicam -6.02 -4.67±0.05 
Prednisolone -7.91 -6.42±0.02 
Progesterone -4.90 -4.13±0.02 
Testosterone -5.54 -4.52±0.03 
Conclusions 
The tests performed in this work indicate that the ideal assay conditions for skin-PAMPA permeability 
measurements are 4 hours of incubation time and with the use of stirring. This incubation time allows the 
determination of permeability of the greatest number of compounds while stirring diminishes the thickness 
of the aqueous boundary layer. Concerning membrane retention, this parameter is in general low (0-0.30). 
It has been observed that the membrane retention depends on the incubation time and also is related to 
the lipophilicity of compounds when they are in their neutral form. On the other hand, it has been 
demonstrated that the skin-PAMPA membrane is affected at basic pH values, so it is advisable to perform 
experiments below pH 8 to avoid damaging the membrane. The results shown here indicate good 
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agreement between human skin permeability and skin-PAMPA permeability established under appropriate 
assay conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Correlation between human skin permeability and 
skin-PAMPA permeability. 
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Appendix 
Equation (6) can be derived as follows for a drug equilibrated between an aqueous compartment and a 
membrane: 
 
 
𝑅M =
𝐶membrane𝑉membrane
𝐶membrane𝑉membrane + 𝐶water𝑉water
 
 
Therefore: 𝑅M =
1
1+
𝐶water𝑉water
𝐶membrane𝑉membrane
=
1
1+
1
𝐷
 ∙ 
𝑉water
Vmembrane
 
 
Because:    
1
𝐷
= 10−log 𝐷   and   
𝑉water
𝑉membrane
= 10
log
𝑉water
𝑉membrane
 
 
 
𝑅M =
1
1+10
−log𝐷+lo𝑔
𝑉water
𝑉membrane
    (6) 
 
It should be noted that the derivation assumes that drug absorption to the filter material can be 
ignored. If this is not accurate then a constant can be added in order to improve the fit for less lipophilic 
compounds (equation 6b) 
𝑅M = Constant + (
1
1+10
−log𝐷+log
𝑉water
𝑉membrane
)  (6b) 
 
 
©2020 by the authors; licensee IAPC, Zagreb, Croatia. This article is an open-access article distributed under the terms and 
conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/)  
